Update on the Therapeutic Drug Monitoring in IBD: Is it Time We Use it in Situations other Than Loss of Response

Summit Co-Chair Edward Shahady, MD, asks Faculty Member John E. Anderson, MD, about this epidemic called diabetes.

Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...